KBC Group
SANA icon

KBC Group’s Sana Biotechnology SANA Stock Holding History

KBC Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,873
Closed -$29K – 1909
2024
Q1 		$29K Buy
+2,873
New +$21.5K ﹤0.01% 1782

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

KBC Group's SANA Position: Q2 2024 in Review

KBC Group sold out of Sana Biotechnology (SANA) in Q2 2024, closing a stake of 2,873 shares — an estimated $29K sold.

KBC Group first reported a position in SANA in Q1 2024 and held it in 1 quarter. The position peaked at $29K in Q1 2024. 148 funds tracked by Wall St. Rank hold SANA as of Q2 2024.

  • KBC Group reported no remaining Sana Biotechnology position as of Q2 2024 after selling out during the quarter.
  • KBC Group sold 2,873 Sana Biotechnology shares in Q2 2024, an estimated $29K.
  • KBC Group first reported a position in Sana Biotechnology in Q1 2024 and held it in 1 quarter.
  • KBC Group's Sana Biotechnology position peaked at $29K in Q1 2024.
  • 148 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2024.

Based on KBC Group's 13F filing for Q2 2024, filed 17 Jul 2024.